InvestorsHub Logo

wadirum1

03/13/20 10:45 AM

#72634 RE: wadirum1 #72633

What the heck was that filing??

So, it gives some financials. Company has zero on all values for its balance sheet, except it somehow managed to owe $125K again. And yet it claims to have had $1.4M in revenues. Now, how do you have that much activity, but yet have ZERO on all areas of balance sheet (other than debt)?

And if revs are $1.4M and costs are $0.8M, then how does that result in a LOSS?

And there is the increase in A/S to 2 billion and the reverse stock split that they hope to do as soon as they can scrape together the money to pay their transfer agent to send info to FINRA. Huh??


We have mailed Articles of Amendment on March 3, 2020, which will be effective when received and file stamped by the Florida Secretary of State, to increase the number of shares of common stock we are authorized to issue to two billion shares from 700,000,000 shares of common stock, $0.001 par value per share. At the date of this offering circular, we have 699,991,000 shares of common stock issued and outstanding.



We authorized a reverse stock split in a ratio of 1:35, the effectiveness of which is subject to market announcement by the Financial Industry Regulatory Authority for which application has been made but we have insufficient financial resources to pay its transfer agent to provide information requested by FINRA and to implement the reverse stock split. The shares offered by this offering circular will be subject to the reverse split when it is announced by FINRA and this offering circular will be amended according. When the reverse split is effective, the 700,000,000 shares offered by this offering circular will be 2,000,000 shares and the price to the public will be $6.30 per share.



We have no operations or facilities at the date of this offering circular. We plan to use the net proceeds from the offering to establish facilities and to manufacture low cost insulin for human use using proprietary manufacturing technology developed by Ronald E. Zimmerman, one of our founders and directors.